Express News | Pharmather Holdings Ltd - Receipt of a Complete Response Letter ("Crl") for Its Priority Original Abbreviated New Drug Application for Ketamine

Moomoo 24/7Apr 18 16:00 ET

Express News | Pharmather Holdings Ltd: Has Completed Necessary Tests and Responses to Address Fda's Comments

Moomoo 24/7Apr 18 16:00 ET

PharmaTher Expects FDA to Decide on Ketamine Approval by April 29

Seeking AlphaJan 10 11:56 ET

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of psychedeli

BenzingaOct 2, 2023 09:46 ET

PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance

The Food and Durg Administration (FDA) has accepted specialty biopharma company PharmaTher Holdings' (OTCQB:PHRRF) new drug application for a racemic ketamine product.

BenzingaSep 27, 2023 14:38 ET

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035. Top players featured include known names such as COMPASS Path

BenzingaSep 12, 2023 16:35 ET